Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Bright White

19.06.2012
Organic acids prevent decomposition and discoloration of an antitumor agent

Would you want to swallow a tablet that’s yellow rather than its usual white? Would this effect be harmless and would the drug still be efficient?



Researchers in India have now described an approach to maintaining the color and activity of an antitumor agent. As they report in Chemistry - An Asian Journal, acids can protect powders of the drug from discoloration and loss of activity.

The anticancer agent temozolomide is stable in the presence of acid, but when white tablets of the drug are stored for an extended period of time, they turn light pink or tan. This discoloration is indicative of degradation by water in neutral or basic conditions, which lowers the effectiveness of the drug, and has the potential to disconcert patients.

Ashwini Nangia and co-workers at the University of Hyderabad, India, have developed a method to increase the chemical stability of temozolomide and prevent discoloration. They made solids comprising temozolomide that is intimately mixed with an acid, forming so-called cocrystals.

The acid effectively protects the drug from degradation, and the cocrystals showed no signs of discoloration for over six months, even in humid air. As acids, they chose safe organic acids such as acetic acid (found in vinegar), succinic acid (a fermentation byproduct) and oxalic acid (found in rhubarb). Preliminary assessment of the pharmacological properties of the cocrystals indicates that especially those incorporating succinic acid and oxalic acid could be suitable for use in formulation development.

Author: Ashwini Nangia, University of Hyderabad, India, http://202.41.85.161/~an/

Title: Crystal Engineering of Stable Temozolomide Cocrystals

Chemistry - An Asian Journal, Permalink to the article: http://dx.doi.org/10.1002/asia.201200205

Ashwini Nangia | Wiley-VCH
Further information:
http://202.41.85.161/~an/
http://www.aces-chemistry-society-publishing.org/aces.html

More articles from Life Sciences:

nachricht New image of a cancer-related enzyme in action helps explain gene regulation
05.06.2020 | Penn State

nachricht Protecting the Neuronal Architecture
05.06.2020 | Universität Heidelberg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Restoring vision by gene therapy

Latest scientific findings give hope for people with incurable retinal degeneration

Humans rely dominantly on their eyesight. Losing vision means not being able to read, recognize faces or find objects. Macular degeneration is one of the major...

Im Focus: Small Protein, Big Impact

In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.

Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding...

Im Focus: K-State study reveals asymmetry in spin directions of galaxies

Research also suggests the early universe could have been spinning

An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...

Im Focus: New measurement exacerbates old problem

Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.

Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

New image of a cancer-related enzyme in action helps explain gene regulation

05.06.2020 | Life Sciences

Silicon 'neurons' may add a new dimension to computer processors

05.06.2020 | Physics and Astronomy

Protecting the Neuronal Architecture

05.06.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>